IRF1 and Miyoshi myopathy: Furthermore, IRF1 protein levels decreased over time after treatment with panobinostat and IFN-γ in combination (Figure 3D), although IFN-γ alone continuously increased IRF1 protein levels over 48 hours in these MM cells (Figure 1B).